3 results
This study is designed to assess the efficacy of pralsetinib as compared to Investigator*s choice platinum-based chemotherapy regimen for patients with metastatic NSCLC harboring an oncogenic RET fusion and who have not received prior systemic…
The goal of this study is to evaluate if serum FGF23 levels are directly related to cardiovascular calcification, measured as arterial stiffness with pulse wave velocity. The primary objective is to evaluate if elevated serum FGF23 and decreased…
To determine the rate of detection of sub-clinical atrial AF (* 5 minutes) within an average of 12 months following implant of the Confirm® Implantable Cardiac Monitor in patients with known cardiovascular risk factors and left atrial enlargement,…